Open Access

Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma‑like carcinoma

  • Authors:
    • Chun‑Yu Lin
    • Yu‑Chuan Chang
    • I‑Ting Wang
    • Meng‑Heng Hsieh
    • Chih‑Wei Wang
    • Shu‑Min Lin
    • Ching‑Yang Wu
    • Yueh‑Fu Fang
  • View Affiliations

  • Published online on: October 2, 2019     https://doi.org/10.3892/ol.2019.10954
  • Pages: 6143-6149
  • Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pretreatment tumor metabolic burden, measured using fluorine‑18 fluorodeoxyglucose positron emission tomography/computerized tomography (18F‑FDG PET/CT), has been demonstrated to predict outcomes in various types of malignancies. Additionally, Epstein‑Barr virus (EBV) serum titer is associated with stages of pulmonary lymphoepithelioma‑like carcinoma (LELC). The present study aimed to investigate the prognostic value of the functional parameters of 18F‑FDG PET/CT in pulmonary LELC and their association with serum EBV DNA. The present retrospective study analyzed data from 71 patients with pulmonary LELC; among these, 32 patients with pulmonary LELC underwent pretreatment 18F‑FDG PET/CT staging between January 2008 and December 2016. EBV viral load and functional parameters of 18F‑FDG PET/CT were used for survival analysis. Multivariate analysis identified tumor stage IV as a significant predictor of poor progression‑free survival [hazard ratio (HR), 4.85; P=0.049], whereas elevated total metabolic tumor volume (MTV ≥72.6 ml) independently predicted worse overall survival (OS; HR, 12.59; P=0.024). Pretreatment serum EBV DNA titer was significantly positively associated with total MTV (P=0.0337) and total lesion glycolysis (TLG; P=0.0093), but could not predict outcomes. Total MTV was an independent predictor of OS, and may guide clinical management for pulmonary LELC.

Related Articles

Journal Cover

December 2019
Volume 18 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Lin, C., Chang, Y., Wang, I., Hsieh, M., Wang, C., Lin, S. ... Fang, Y. (2019). Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma‑like carcinoma. Oncology Letters, 18, 6143-6149. https://doi.org/10.3892/ol.2019.10954
MLA
Lin, C., Chang, Y., Wang, I., Hsieh, M., Wang, C., Lin, S., Wu, C., Fang, Y."Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma‑like carcinoma". Oncology Letters 18.6 (2019): 6143-6149.
Chicago
Lin, C., Chang, Y., Wang, I., Hsieh, M., Wang, C., Lin, S., Wu, C., Fang, Y."Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma‑like carcinoma". Oncology Letters 18, no. 6 (2019): 6143-6149. https://doi.org/10.3892/ol.2019.10954